REFERENCES
[1] Nilsson, L., Brockow, K., Alm, J., Cardona, V., Caubet, J. C., Gomes, E., … & Zanoni, G. (2017). Vaccination and allergy: EAACI position paper, practical aspects. Pediatric Allergy and Immunology, 28(7), 628-640.
[2] Institute of Medicine (US). Committee to Review Adverse Effects of Vaccines, Stratton, K. R., & Clayton, E. W. (2012). Adverse effects of vaccines: evidence and causality.
[3] Micheletti, F., Peroni, D., Piacentini, G., Schweiger, V., Mirandola, R., Chiesa, E., & Zanoni, G. (2012). Vaccine allergy evaluation and management at the specialized Green Channel Consultation Clinic. Clinical & Experimental Allergy, 42(7), 1088-1096.
[4] Su, J. R., Moro, P. L., Ng, C. S., Lewis, P. W., Said, M. A., & Cano, M. V. (2019). Anaphylaxis after vaccination reported to the vaccine adverse event reporting system, 1990-2016. Journal of Allergy and Clinical Immunology, 143(4), 1465-1473.
[5] McNeil, M. M., Weintraub, E. S., Duffy, J., Sukumaran, L., Jacobsen, S. J., Klein, N. P., … & DeStefano, F. (2016). Risk of anaphylaxis after vaccination in children and adults. Journal of Allergy and Clinical Immunology, 137(3), 868-878.
[6] Gold, M., Goodwin, H., Botham, S., Burgess, M., Nash, M., & Kempe, A. (2000). Re-vaccination of 421 children with a past history of an adverse vaccine reaction in a special immunisation service. Archives of disease in childhood, 83(2), 128-131.
[7] Wood, R. A. (2013). Allergic reactions to vaccines. Pediatric Allergy and Immunology, 24(6), 521-526.
[8] Kimberlin, D. W., Brady, M. T., Jackson, M. A., Long, S. S., & American Academy of Pediatrics. (2015). Red book: 2015 report of the Committee on Infectious Diseases. American academy of pediatrics, 432, 445.
[9] Halsey, N. A., Griffioen, M., Dreskin, S. C., Dekker, C. L., Wood, R., Sharma, D., … & Kelso, J. M. (2013). Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS. Vaccine, 31(51), 6107-6112.
[10] Franceschini, F., Bottau, P., Caimmi, S., Cardinale, F., Crisafulli, G., Liotti, L., … & Caffarelli, C. (2018, May). Evaluating children with suspected allergic reactions to vaccines for infectious diseases. In Allergy & Asthma Proceedings (Vol. 39, No. 3).
[11] Muraro, A., Worm, M., Alviani, C., Cardona, V., DunnGalvin, A., Garvey, L. H., … & European Academy of Allergy and Clinical Immunology, Food Allergy, Anaphylaxis Guidelines Group. (2022). EAACI guidelines: Anaphylaxis (2021 update). Allergy, 77(2), 357-377.
[12] Gold, M. S., Amarasinghe, A., Greenhawt, M., Kelso, J. M., Kochhar, S., Thong, B. Y. H., … & Law, B. (2022). Anaphylaxis: Revision of the Brighton collaboration case definition. Vaccine.
[13] Arcolaci, A., Bronte, V., & Zanoni, G. (2021). Immunization practices and risk of anaphylaxis: a current update, comprehensive of COVID-19 vaccination data. Current Opinion in Allergy and Clinical Immunology, 21(5), 418-425.
[14] Miller ER, McNeil MM, Moro, et al. The reporting sensitivity of the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis and for GuillainBarre syndrome. Vaccine 2020; 38:7458–7463
[15] Bohlke, K., Davis, R. L., Marcy, S. M., Braun, M. M., DeStefano, F., Black, S. B., … & Vaccine Safety Datalink Team. (2003). Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics, 112(4), 815-820.
[16] Castells MC, Phillips EJ. Maintaining Safety with SARS-CoV-2 Vaccines. N Engl J Med. 2021;384(7):643-649.
[17] Caubet, J. C., & Ponvert, C. (2014). Vaccine allergy. Immunology and Allergy Clinics, 34(3), 597-613.
[18] Echeverría-Zudaire, L. A., Ortigosa-del Castillo, L., Alonso-Lebrero, E., Álvarez-García, F. J., Cortés-Álvarez, N., García-Sánchez, N., & Martorell-Aragonés, A. (2015). Consensus document on the approach to children with allergic reactions after vaccination or allergy to vaccine components. Allergologia et Immunopathologia, 43(3), 304-325.
[19] Aytekin, E. S., Şekerel, B. E., & Şahiner, Ü. M. (2021). Allergic reactions during childhood vaccination and management. The Turkish Journal of Pediatrics, 63(6), 941-954.
[20] Sarti L, Lezmi G, Mori F, Giovannini M, Caubet JC. Diagnosis and management of hypersensitivity reactions to vaccines. Expert Rev Clin Immunol. 2020 Sep;16(9):883-896. doi: 10.1080/1744666X.2020.1814745. Epub 2020 Sep 29. PMID: 32838592.
[21] Zanoni, G., Migliorini, M., Gallo, T., Guidolin, L., & Schena, D. (2020). Recurrent injection site reactions to vaccines: two clinical patterns of presentation. Vaccine, 38(45), 6985-6989.
[22] Bergfors E, Inerot A, Falk L, Nyström U, Trollfors B. Patch testing children with aluminium chloride hexahydrate in petrolatum: A review and a recommendation. Contact Dermatitis. 2019 Aug;81(2):81-88. doi: 10.1111/cod.13303. Epub 2019 May 31. PMID: 31066081
[23] Bergfors E, Trollfors B. Sixty-four children with persistent itching nodules and contact allergy to aluminium after vaccination with aluminium-adsorbed vaccines-prognosis and outcome after booster vaccination. Eur J Pediatr. 2013 Feb;172(2):171-7. doi: 10.1007/s00431-012-1841-2. Epub 2012 Oct 11. PMID: 23052615.
[24] Caubet, J. C., Rudzeviciene, O., Gomes, E., Terreehorst, I., Brockow, K., & Eigenmann, P. A. (2014). Managing a child with possible allergy to vaccine. Pediatric Allergy and Immunology, 25(4), 394-403.
[25] https://www.hopkinsvaccine.org/cc-mmr.html
[26] Kelso JM, Greenhawt MJ, Li JT, et al. Adverse reactions to vaccines practice parameter 2012 update. J Allergy Clin Immunol 2012;130: 25-43
[27] Wood RA, Setse R, Halsey N. Clinical Immunization Safety Assessment (CISA) Network Hypersensitivity Working Group. Irritant skin test reactions to common vaccines. J Allergy Clin Immunol. 2007; 120: 478- 481.
[28] Lopez-Serrano, M. C., Caballero, M. T., Barranco, P., & Martinez-Alzamora, F. (1996). Booster responses in the study of allergic reactions to beta-lactam antibiotics. Journal of investigational allergology & clinical immunology, 6(1), 30-35.
[29] Wood, R. A., Berger, M., Dreskin, S. C., Setse, R., Engler, R. J., Dekker, C. L., … & Hypersensitivity Working Group of the Clinical Immunization Safety Assessment (CISA) Network. (2008). An algorithm for treatment of patients with hypersensitivity reactions after vaccines. Pediatrics, 122(3), e771-e777.
[30] Miyazawa, H., Inouye, S., & Sakaguchi, M. (2000). Sensitization to gelatin in children with systemic non-immediate-type reactions to varicella vaccines. Annals of Allergy, Asthma & Immunology, 84(3), 341-344.
[31] Des Roches, A., Paradis, L., Gagnon, R., Lemire, C., Bégin, P., Carr, S., … & De Serres, G. (2012). Egg-allergic patients can be safely vaccinated against influenza. Journal of Allergy and Clinical Immunology, 130(5), 1213-1216.
[32] Turner, P. J., Southern, J., Andrews, N. J., Miller, E., Erlewyn-Lajeunesse, M., Doyle, C., … & Thomas, H. M. (2015). Safety of live attenuated influenza vaccine in atopic children with egg allergy. Journal of Allergy and Clinical Immunology, 136(2), 376-381.
[33] Des Roches, A., Samaan, K., Graham, F., Lacombe-Barrios, J., Paradis, J., Paradis, L., & De Serres, G. (2015). Safe vaccination of patients with egg allergy by using live attenuated influenza vaccine. The Journal of Allergy and Clinical Immunology: In Practice, 3(1), 138-139.
[34] Grohskopf, L. A., Alyanak, E., Broder, K. R., Walter, E. B., Fry, A. M., & Jernigan, D. B. (2019). Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2019–20 influenza season. MMWR Recommendations and reports, 68(3), 1.
[35] World Health Organization. (2013). Rotavirus vaccines: WHO position paper—January 2013. Weekly Epidemiological Record= Relevé épidémiologique hebdomadaire, 88(05), 49-64.
[36] Jackson, L. A., Carste, B. A., Malais, D., & Froeschle, J. (2002). Retrospective population-based assessment of medically attended injection site reactions, seizures, allergic responses and febrile episodes after acellular pertussis vaccine combined with diphtheria and tetanus toxoids. The Pediatric infectious disease journal, 21(8), 781-786.
[37] Cheng, D. R., Perrett, K. P., Choo, S., Danchin, M., Buttery, J. P., & Crawford, N. W. (2015). Pediatric anaphylactic adverse events following immunization in Victoria, Australia from 2007 to 2013. Vaccine, 33(13), 1602-1607.
[38] Beveridge, M. G., Polcari, I. C., Burns, J. L., Adler, A., Hendrickson, B., & Stein, S. L. (2012). Local vaccine site reactions and contact allergy to aluminum. Pediatric dermatology, 29(1), 68-72.
[39] Kattan, J. D., Konstantinou, G. N., Cox, A. L., Nowak-Węgrzyn, A., Gimenez, G., Sampson, H. A., & Sicherer, S. H. (2011). Anaphylaxis to diphtheria, tetanus, and pertussis vaccines among children with cow’s milk allergy. Journal of allergy and clinical immunology, 128(1), 215-218.
[40] DiMiceli, L., Pool, V., Kelso, J. M., Shadomy, S. V., Iskander, J., & VAERS Team. (2006). Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS). Vaccine, 24(6), 703-707.
[41] Parisi, C. A. S., Smaldini, P. L., Gervasoni, M. E., Maspero, J. F., & Docena, G. H. (2013). Hypersensitivity reactions to the Sabin vaccine in children with cow’s milk allergy. Clinical & Experimental Allergy, 43(2), 249-254.
[42] Arroabarren, E., Anda, M., & Sanz, M. L. (2016). Anaphylaxis to pneumococcal vaccine; CRM (197): novel cause of vaccine allergy. Pediatric Allergy and Immunology, 27(4), 433-437.
[43] Myers, T. R., McNeil, M. M., Ng, C. S., Li, R., Lewis, P. W., & Cano, M. V. (2017). Adverse events following quadrivalent meningococcal CRM-conjugate vaccine (Menveo®) reported to the Vaccine Adverse Event Reporting system (VAERS), 2010–2015. Vaccine, 35(14), 1758-1763.
[44] Perez-Vilar, S., Dores, G. M., Marquez, P. L., Ng, C. S., Cano, M. V., Rastogi, A., … & Duffy, J. (2022). Safety surveillance of meningococcal group B vaccine (Bexsero®), Vaccine Adverse Event Reporting System, 2015–2018. Vaccine, 40(2), 247-254.
[45] Markowitz, L. E., Dunne, E. F., Saraiya, M., Chesson, H. W., Curtis, C. R., Gee, J., … & Unger, E. R. (2014). Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report: Recommendations and Reports, 63(5), 1-30.
[46] Badiu, I., Geuna, M., Heffler, E., & Rolla, G. (2012). Hypersensitivity reaction to human papillomavirus vaccine due to polysorbate 80. Case Reports, 2012, bcr0220125797.
[47] Greenhawt, M., Abrams, E. M., Shaker, M., Chu, D. K., Khan, D., Akin, C., … & Golden, D. B. (2021). The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and international consensus approach. The Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3546-3567.
[48] Greenhawt M, Abrams EM, Oppenheimer J, Vander Leek TK, Mack DP, Singer AG, et al. The COVID-19 pandemic in 2021: avoiding overdiagnosis of anaphylaxis risk while safely vaccinating the world. J Allergy Clin Immunol Pract 2021;9:1438-41.
[49] Banerji A, Wickner PG, Saff R, Stone CA Jr, Robinson LB, Long AA, et al. mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach. J Allergy Clin Immunol Pract 2021;9:1423-37.
[50] Greenhawt, M., Shaker, M., & Golden, D. B. (2021). PEG/polysorbate skin testing has no utility in the assessment of suspected allergic reactions to SARS-CoV-2 vaccines. The Journal of Allergy and Clinical Immunology: In Practice, 9(9), 3321-3322.
[51] American Academy of Pediatrics. Active and passive immunization. In: Pickering LK, editor. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th edn Elk Grove Village, IL: American Academy of Pediatrics; 2009. p. 48.
[52] Kelso JM. Update on vaccination guidelines for allergic children. Expert Rev Vaccines. 2009;8:1541—6.
[53] Zent O, Arras-Reiter C, Broeker M, Hennig R. Immediate allergic reactions after vaccinations — a post-marketing surveillance review. Eur J Pediatr. 2002;161:21—5.
[54] Eggesbo M, Botten G, Halvorsen R, Magnus P. The prevalence of allergy to egg: a population-based study in young children. Allergy. 2001;56:403—11.
[55] Zanoni, G., Puccetti, A., Dolcino, M., Simone, R., Peretti, A., Ferro, A., & Tridente, G. (2008). Dextran-specific IgG response in hypersensitivity reactions to measles-mumps-rubella vaccine. Journal of Allergy and Clinical Immunology, 122(6), 1233-1235.
[56] Zanoni, G., Zanotti, R., Schena, D., Sabbadini, C., Opri, R., & Bonadonna, P. (2017). Vaccination management in children and adults with mastocytosis. Clinical & Experimental Allergy, 47(4), 593-596.
[57] Gallo, G., Mel, R., Ros, E., & Filia, A. (2019). Guide to contraindications to vaccination (2018 update). Rapporti ISTISAN-Istituto Superiore di Sanità, (19/3).
Figure 1: Algorithm to select and manage vaccination of patients who refer a previous suggestive allergic reaction to a vaccine.